Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Microorganisms|September 28, 2023
Propylene Glycol Potentiates the Inhibitory Action of CTZ Paste on Antibiotic-Resistant Enterococcus faecalis Isolated from the Root Canal: An In Vitro StudyJesús Yareli Rayos-Verdugo, Fernando Rivera-Chaparro, Gloria Yolanda Castro-Salazar, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)Fernando Rivera, M Eugenia Vega-Villegas, Marta López-Brea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2Teresa Macarulla, Roberto Pazo-Cid, Carmen Guillén-Ponce, et al.
The Oncologist|May 31, 2012
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, M Luisa Maestro, Auxiliadora Gómez-España, et al.
The New England Journal of Medicine|September 12, 2008
Platinum-based chemotherapy plus cetuximab in head and neck cancerJan B Vermorken, Ricard Mesia, Fernando Rivera, et al.
Critical Reviews in Oncology/Hematology|December 30, 2008
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III studyJavier Sastre, Enrique Aranda, Bartomeu Massutí, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinomaFernando Rivera, Maica Galán, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
European Heart Journal|March 4, 2025
Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working groupScott C Adams, Fernando Rivera-Theurel, Jessica M Scott, et al.
Cancer Chemotherapy and Pharmacology|March 4, 2010
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinomaFernando Rivera, Maica Galán, Josep Tabernero, et al.
Pageof 20